TrialOncotarget2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.
Anish Thomas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this papertrialcites it